{"nct_id":"NCT01024231","title":"Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2009-12-14","start_date_type":"ACTUAL","primary_completion_date":"2014-02-04","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}